作者
Gregor Gryglewski, Manfred Klöbl, Neydher Berroterán-Infante, Lucas Rischka, Theresa Balber, Thomas Vanicek, Verena Pichler, Alexander Kautzky, Eva-Maria Klebermass, Murray Bruce Reed, Chrysoula Vraka, Marius Hienert, Gregory Miles James, Leo Silberbauer, Godber Mathis Godbersen, Jakob Unterholzner, Paul Michenthaler, Markus Hartenbach, Edda Winkler-Pjrek, Wolfgang Wadsak, Markus Mitterhauser, Andreas Hahn, Marcus Hacker, Siegfried Kasper, Rupert Lanzenberger
发表日期
2019/6/1
期刊
European Neuropsychopharmacology
卷号
29
期号
6
页码范围
711-719
出版商
Elsevier
简介
Pharmacological imaging of the effects of selective serotonin reuptake inhibitors (SSRI) may aid the clarification of their mechanism of action and influence treatment of highly prevalent neuropsychiatric conditions if the detected effects could be related to patient outcomes. In a randomized double-blind design, 38 healthy participants received a constant infusion of 8 mg citalopram or saline during either their first or second of two PET/MR scans. Resting-state functional MRI (fMRI) was acquired simultaneously with PET data on the binding of serotonin transporters (5-HTT) using [11C]DASB. Three different approaches for modeling of pharmacological fMRI response were tested separately. These relied on the use of regressors corresponding to (1) the drug infusion paradigm, (2) time courses of citalopram plasma concentrations and (3) changes in 5-HTT binding measured in each individual, respectively …
引用总数
201920202021202220232024125311
学术搜索中的文章